MDM2–p53 pathway in hepatocellular carcinoma

X Meng, DA Franklin, J Dong, Y Zhang - Cancer research, 2014 - AACR
Abnormalities in the TP53 gene and overexpression of MDM2, a transcriptional target and
negative regulator of p53, are commonly observed in cancers. The MDM2–p53 feedback …

[HTML][HTML] Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis

J Liu, Q Ma, M Zhang, X Wang, D Zhang, W Li… - European journal of …, 2012 - Elsevier
BACKGROUND: The prognostic significance of p53 aberration in hepatocellular carcinoma
(HCC) remains inconclusive. This systematic review and meta-analysis aimed to provide …

[HTML][HTML] The effect of encapsulated apigenin nanoparticles on HePG-2 cells through regulation of P53

MM Mabrouk Zayed, HA Sahyon, NAN Hanafy… - Pharmaceutics, 2022 - mdpi.com
Apigenin (Ap) is one of the most important natural flavonoids that has potent anticancer
activity. This study was designed, for the first time, to load Ap into chitosan to improve its …

MiR-663, a microRNA targeting p21WAF1/CIP1, promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma

C Yi, Q Wang, L Wang, Y Huang, L Li, L Liu, X Zhou… - Oncogene, 2012 - nature.com
MicroRNAs (miRNAs) may function as either oncogenes or tumor suppressors in the
malignant progression of different tumor types. MiR-663 was recently reported to be …

[PDF][PDF] Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation

N Embade, D Fernández‐Ramos, M Varela‐Rey… - …, 2012 - Wiley Online Library
Hu antigen R (HuR) is a central RNA‐binding protein regulating cell dedifferentiation,
proliferation, and survival, which are well‐established hallmarks of cancer. HuR is frequently …

[HTML][HTML] Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma

L Zhan, H Cao, G Wang, Y Lyu, X Sun, J An, Z Wu… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Mitochondria are highly dynamic and undergo constant fusion and fission that are essential
for maintaining physiological functions of cells. Recently, we have reported that increased …

[HTML][HTML] Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma

X Liu, X Chi, Q Gong, L Gao, Y Niu, X Chi, M Cheng… - PloS one, 2015 - journals.plos.org
Hepatocellular carcinoma (HCC) and liver cirrhosis are associated with high mortality
worldwide. Currently, alpha-fetoprotein (AFP) is used as a standard serum marker for the …

Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma

S Krautbauer, EM Meier, L Rein-Fischboeck… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Lipid composition affects membrane function, cell proliferation and cell death and is
changed in cancer tissues. Hepatocellular carcinoma (HCC) is an aggressive cancer and …

Prevalence of human papillomavirus, Epstein–Barr virus, p21, and p53 expression in sinonasal inverted papilloma, nasal polyp, and hypertrophied turbinate in Hong …

CL Sham, KF To, PKS Chan, DLY Lee, MCF Tong… - Head & …, 2012 - Wiley Online Library
Background The purpose of this study of human papillomavirus (HPV), Epstein–Barr virus
(EBV), p21, and p53 in sinonasal inverted papilloma (IP) was to help elucidate its …

MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53

W Wang, JW Cheng, JJ Qin, B Hu, X Li, B Nijampatnam… - Cancer letters, 2019 - Elsevier
The overexpression of the MDM2 oncoprotein frequently occurs in hepatocellular carcinoma
(HCC). Small molecules that inhibit MDM2-p53 binding show efficacy against p53 wild-type …